MYCELX Technologies Corporation
MYX.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | £5 | £11 | £10 | £8 |
| % Growth | -55% | 8.8% | 18.3% | – |
| Cost of Goods Sold | £4 | £7 | £6 | £5 |
| Gross Profit | £1 | £4 | £4 | £3 |
| % Margin | 27.4% | 35.7% | 44.3% | 38.6% |
| R&D Expenses | £0 | £0 | £0 | £0 |
| G&A Expenses | £5 | £7 | £0 | £7 |
| SG&A Expenses | £5 | £7 | £8 | £7 |
| Sales & Mktg Exp. | £0 | £0 | £8 | £0 |
| Other Operating Expenses | £0 | £0 | £0 | £0 |
| Operating Expenses | £6 | £7 | £8 | £7 |
| Operating Income | -£5 | -£3 | -£4 | -£2 |
| % Margin | -92.9% | -30.5% | -35.7% | -17.8% |
| Other Income/Exp. Net | £2 | -£0 | £0 | £0 |
| Pre-Tax Income | -£3 | -£3 | -£4 | -£1 |
| Tax Expense | £0 | £0 | £0 | £0 |
| Net Income | -£3 | -£4 | -£4 | -£1 |
| % Margin | -55.5% | -34% | -39.8% | -16.8% |
| EPS | -0.12 | -0.16 | -0.18 | -0.073 |
| % Growth | 25% | 11.1% | -145.6% | – |
| EPS Diluted | -0.12 | -0.16 | -0.18 | -0.073 |
| Weighted Avg Shares Out | 23 | 23 | 22 | 19 |
| Weighted Avg Shares Out Dil | 23 | 23 | 22 | 19 |
| Supplemental Information | – | – | – | – |
| Interest Income | £0 | £0 | £0 | £0 |
| Interest Expense | £0 | £0 | £0 | £0 |
| Depreciation & Amortization | £0 | £1 | £1 | £1 |
| EBITDA | -£2 | -£2 | -£2 | £0 |
| % Margin | -45.4% | -22.6% | -24.8% | 0.2% |